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ABBREVIATIONS AND ACRONYMS 
¾ ACA  :  Anterior Cerebral Artery. 
¾ AICA  :  Anterior Inferior Cerebellar artery 
¾ AF  :  Atrial Fibrillation. 
¾ BA  :  Basilar Artery 
¾ BP  :  Blood Pressure 
¾ DM  :  Diabetes mellitus 
¾ DWI  :  Diffusion Weighted imaging 
¾ HDL  :  High Density Lipoproteins 
¾ HT  :  Hypertension 
¾ ICA  :  Internal Carotid Artery  
¾ LDL  :  Low Density Lipoproteins 
¾ MCA  :  Middle Cerebral Artery 
¾ MRI  :  Magnetic Resonance Imaging 
¾ mRS  :  Modified Ranikin Score 
¾ NECT  :  Non Enhanced Computerized Tomogram 
¾ NIHSS  :  National Institute of Health Stroke Scale 
¾ PCA  :  Posterior Cerebral Artery 
¾ PICA  :  Posterior Inferior Cerebellar artery 
¾ SCA  :  Superior Cerebellar Artery 
¾ TIA:  :  Transient Ischemic Attacks 
¾ TGL  :  Triglycerides 
  
 
 KEY TO MASTER CHART 
A  :  Aphasia 
AF  :  Atrial Fibrillation 
AD                             :        Arterial Disease 
Amx  :  Amaurosis Fugax 
Atx  :  Ataxia 
B  :  Both 
CD  :  Cardiac Disease 
D  :  Dysarthria 
DM  :  Diabetes Mellitus 
Dip  :  Diplopia 
FB  :  Facio Brachial Monoparesis 
F  :  Female 
HA  :  Hemianopia 
HT  :  Hypertension 
L  :  Left 
LOC  :  Loss of Consciousness 
M  :  Male  
N  :  No 
N & V  :  Nausea and Vomiting 
P  :  Posterior Circulation 
R  :  Right 
U  :  Undetermined 
Vt  :  Vertigo 
Y  :  Yes 
      INTRODUCTION 
                Cerebrovascular disease is the third leading cause of death in developed 
countries after heart disease and cancer; the overall prevalence is 794 per 100,000. It is 
estimated that more than 700,000 patients have a stroke each year in the United States. 
The loss of these patients from the work force and the extended hospitalization they 
require during recovery make the economic impact of the disease one of the most 
devastating in medicine. 
         About 15-20% of patients with stroke have a preceding TIA, making it one of the 
common neurologic problems. Four to 20 percent of patients who have a TIA, experience 
a stroke within the following 90 days; one half of those strokes occur within 48 hours. 
Promptly recognizing patients who are at high risk of progressing to stroke provide us a 
golden opportunity for stroke prevention. This depends upon accurately identifying the 
cause of symptoms, and the nature, location, and severity of causative cardiac, 
hematologic, and cerebrovascular abnormalities.  
                   TIA being a clinical diagnosis, there is a significant variation among 
physicians and neurologists in diagnosing this condition. In one series, majority (81%) of 
the TIA referrals from general practitioners to neurology clinics were for nonvascular 
events. Even the percent agreement among two neurologists for the diagnosis of TIA by 
history varies from 42% to 86%. In such a situation development of a scoring system like 
ABCD2, not only helps in triaging the patients but also acts as a tool in diagnosing and 
further assessing these patients. Although there are studies regarding stroke, currently 
there are no big studies from India regarding the clinical and imaging features in patients 
with TIA. Also ABCD2 score as a tool is not being routinely used even by the 
Neurologist. 
                  Considering the limited information available from India, this study was 
undertaken to determine the utility of ABCD2 scoring system in Indian population and to 
determine the differences in risk factors and clinical profile if any, when compared to 
western population. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Aims and Objectives 
 
1. To analyze the risk factors and clinical profile of transient ischemic attack. 
2. To study the imaging feature in transient ischemic attack. 
3. To evaluate the utility of ABCD2 score in predicting long-term survival and 
stroke risk after TIA 
4. To assess the treatment outcome of transient ischemic attack. 
 
 
 
 
 
LITERATURE REVIEW 
INTRODUCTION — Transient ischemic attack (TIA) is a brief episode of neurologic 
dysfunction resulting from focal temporary cerebral ischemia not associated with cerebral 
infarction.TIA was originally defined clinically by the temporary nature (< 24 hours) of 
the associated neurologic symptoms. However, the arbitrary nature of the 24-hour time 
limit and lack of specific pathophysiologic meaning hampered the clinical and research 
utility of the term "TIA." Recognition of these problems led to a change to a tissue-based 
definition of TIA. The change was driven by advances in neuroimaging that enabled very 
early identification of ischemic brain injury.  
MODERN DEFINITION — As endorsed by 2009 guidelines from the American Heart 
Association and American Stroke Association (AHA/ASA), transient ischemic attack 
(TIA) is now defined as a transient episode of neurologic dysfunction caused by focal 
brain, spinal cord, or retinal ischemia, without acute infarction [1]. In keeping with this 
definition of TIA, ischemic stroke is now defined as an infarction of central nervous 
system tissue. 
TIA was originally defined as a sudden onset of a focal neurologic symptom and/or sign 
lasting less than 24 hours, presumably brought on by a transient decrease in blood supply, 
which rendered the brain ischemic in the area producing the symptom. However, this 
classic definition of TIA was inadequate for several reasons. Most notably, there is risk of 
permanent tissue injury (ie, infarction) even when focal transient neurologic symptoms 
last less than one hour. Thus, the benign connotation of "TIA" has been replaced by an 
understanding that even relatively brief ischemia can cause permanent brain injury.  
The advantages of modern tissue-based definitions of TIA and stroke include the 
following [1,2]  
• The defined end point is biologic (tissue injury, as confirmed or excluded by 
neuroimaging) rather than arbitrary (24 hours).  
• The definition encourages use of neurodiagnostic tests to identify brain injury and 
its cause.  
• The presence or absence of ischemic brain is more accurately reflected.  
An earlier proposal for a tissue-based TIA definition noted that clinical symptoms of TIA 
typically last less than one hour [2]. While this is true, the AHA/ASA did not incorporate 
the phrase "typically less than one hour" in the new definition of TIA because there is no 
time cutoff that reliably distinguishes whether a symptomatic ischemic event will result 
in ischemic infarction [1]. 
Use of the new definitions in epidemiologic studies is likely to modestly alter the 
incidence and prevalence rates of TIA and stroke, but these changes are encouraged by 
the AHA/ASA because they should reflect more accurate diagnosis [1]. One study 
estimated that switching from the classic to the tissue-based definition of TIA could 
reduce the annual incidence of TIA in the United States by 33 percent (range 19 to 44 
percent) and increase the annual incidence of stroke by 7 percent (range 4 to 10 percent) 
[3]. 
OTHER TERMINOLOGY — The terms "acute neurovascular syndrome" and 
"transient symptoms with infarction" (or "cerebral infarction with transient signs") have 
been proposed to supplement TIA in the description of transient symptoms related to 
ischemia. 
Acute neurovascular syndrome — With the new tissue-based definitions of stroke and 
TIA, there may be uncertainty regarding the diagnosis if immediate neuroimaging is not 
available to detect infarction when transient symptoms of brain ischemia occur [1]. The 
AHA/ASA has proposed (but not formally endorsed) consideration of a term such as 
"acute neurovascular syndrome" that can be used in this setting if a diagnostic evaluation 
is not performed or until the diagnostic evaluation is completed. 
Transient symptoms with infarction — The awareness that a classically defined TIA 
(<24 hours in duration) can be associated with irreversible ischemic brain injury led to a 
proposal to label these events as "transient symptoms associated with infarction" (TSI) or 
"cerebral infarction with transient signs" and to distinguish them from transient 
symptoms without infarction [4]. 
While TSI in general has smaller infarct volumes than classically defined ischemic stroke 
(where neurologic deficits persist for ≥ 24 hours), there is no unique size that 
differentiates TSI from ischemic stroke [4]. 
Patients with TSI have a higher short-term risk of recurrent ischemic stroke than patients 
who have transient symptoms without infarction. This conclusion is supported by a 
number of head CT and DWI studies [4-8]. 
RELATIONSHIP OF SYMPTOM DURATION AND INFARCTION — A 
classically defined TIA with symptoms lasting for as little as a few minutes can be 
associated with infarction, whereas a spell lasting for many hours may rarely cause no 
signal changes on diffusion-weighted MRI imaging (DWI). 
Some reports suggest that increased duration of classically defined TIA (<24 hours in 
duration) is associated with a higher probability of infarction on DWI, but the association 
is not absolute [4,9-12]. A systematic analysis of patients with classically defined TIA 
found that symptom duration was not a reliable predictor for the presence of infarction 
(figure 1), even though the mean duration tended to be significantly longer in patients 
with infarction than in those without infarction [4]. 
One potential caveat is that abnormalities on initial imaging such as diffusion-weighted 
(DWI) MRI obtained during or soon after symptoms, may actually be reversible injuries. 
However, most patients with TIA seek medical attention after their symptoms fully 
resolve; a low proportion (≤ 7 percent) of patients with classically defined TIA are 
admitted and scanned at the height of their symptoms [5,9-11]. Therefore, infarcts 
observed in patients with classically defined TIA most likely represent permanent brain 
injury, as the probability of DWI reversibility decreases as the time from symptom onset 
to imaging increases. 
 
 
 
 
Temporal behavior of symptoms in patients with transient ischemic attack (TIA)  
 
Figure 1. The probability density function curve of symptom duration for transient 
symptoms associated with infarction (TSI) indicates the absence of continuity within the 
first 24 hours. The probability density function is the probability that the variable takes a 
value in a given interval and is equal to 1 over its entire range of values. The area under 
curve is almost equal to 1 at around 200 minutes. Also note that the curves for TIA with 
or without infarction overlap (p = 0.82). The distribution of duration of symptoms as 
seen here suggests that symptom duration is not a reliable feature to be used for 
predicting whether a transient neurological spell is associated with infarction.  
DWI: diffusion-weighted magnetic resonance imaging. 
 
DWI is advantageous for evaluating patients who have transient symptoms because it is 
highly sensitive for detecting infarction, thereby confirming an ischemic cause. A 
systematic review found that DWI detects corresponding appropriate ischemic lesions in 
16 to 67 percent of patients with classically defined TIA [13]. Also, the combination of 
DWI with MRI and MRA often provides clues to the underlying pathophysiology. 
DWI also has an advantage in differentiating acute infarction from chronic lesions. One 
study estimated that the amount of error potentially imposed by the use of conventional 
MRI in identifying the clinically responsible infarct in patients with classically defined 
TIA could be as high as 50 percent when compared with DWI [5]. This is, in large part, 
because infarctions associated with classically defined TIA are often very small. A 
volumetric study of TIA-related infarcts showed that 96 percent of all infarcts were 
smaller than 1 mL [4]. The smallest single lesion that was associated with a classically 
defined TIA was 0.17 mL in volume. The mean infarct volume was 0.66 ± 1.20 mL. 
Perfusion-weighted MR imaging (PWI), when used in combination with DWI, may 
improve the accuracy of diagnosis in patients with transient ischemic symptoms [14,15]. 
This is illustrated by a prospective series of 43 patients with classically defined TIA who 
had both studies performed within 48 hours of symptoms onset [15]. Lesions on DWI 
only, PWI only, or both DWI and PWI were observed in 19, 16, and 16 percent of 
patients, respectively. Thus, objective evidence of brain ischemic with either DWI or 
PWI lesion was present in 51 percent. 
INCIDENCE — Transient ischemic attack (TIA) is a common neurologic problem. In a 
mainly white population from Rochester Minnesota, a population-based study reported 
that the incidence rate of TIA was 68 per 100,000 [16]. In the Cincinnati and Northern 
Kentucky region of the United States, where the ethnic and socioeconomic demographics 
are similar to that of the United States as a whole, another population-based study found 
that the adjusted incidence rate for TIA was 83 per 100,000 people, and that blacks and 
men had significantly higher rates of TIA than whites and women [17]. From these data, 
it was estimated that 240,000 TIAs occur each year in the United States. 
The incidence of TIA in other populations has generally been lower than that reported in 
the United States, ranging from about 10 to 56 per 100,000 in various studies worldwide 
[18-21]. 
PATHOPHYSIOLOGIC MECHANISMS — A transient ischemic attack (TIA) should 
be considered a syndrome. These syndromes are conveniently divided into three 
pathophysiologic mechanisms: Large artery low-flow TIA (true TIA) Embolic TIA, 
which may be artery-to-artery, or due to a cardioaortic or unknown source Lacunar or 
small penetrating vessel TIA  
Large artery low flow TIA — Large artery low-flow TIAs are brief (usually minutes to 
a few hours), recurrent, and stereotyped. They are often associated with a tightly stenotic 
atherosclerotic lesion at the internal carotid artery origin or in the intracranial portion of 
the internal carotid artery (siphon) when collateral flow from the circle of Willis to the 
ipsilateral middle or anterior cerebral artery is impaired (figure 2 and figure 3). Other 
important causes include atherosclerotic stenotic lesions in the middle cerebral artery 
stem (figure 4) or at the junction of the vertebral and basilar artery. Any obstructive 
vascular process in the extracranial or intracranial arteries can cause a low-flow TIA 
syndrome if collateral flow to the potentially ischemic brain also is impaired. 
Anatomy of the cerebral arterial circulation 
Embolic TIA — Embolic TIAs are characterized by discrete, usually single, more 
prolonged (hours) episodes of focal neurologic symptoms. As an example, in one study 
that divided patients with TIAs into those with symptoms of short duration (less than 60 
minutes) or long duration (60 minutes or greater), the latter group was much more likely 
to have an embolic source (86 versus 46 percent) [22]. The embolus may arise from a 
pathologic process in an artery, usually extracranial, or from the heart (eg, atrial 
fibrillation or left ventricular thrombus). An ischemic stroke with infarction has occurred 
if symptoms or signs persist beyond 24 hours. However, as previously mentioned, 
symptoms that last less than 24 hours (often only as long as one hour) also may be 
associated with some infarction. If the primary pathologic process is thought to be 
embolic, a diligent search for its source is necessary before therapy to prevent future 
stroke can be initiated.  
Lacunar TIA — Lacunar or penetrating or small vessel TIAs are due to transient 
cerebral ischemia induced by stenosis of one of the intracerebral penetrating vessels 
arising from the middle cerebral artery stem, the basilar or vertebral artery (figure 5), or 
the circle of Willis (figure 2 and figure 3). Occlusion of these small intracerebral 
penetrating vessels usually is due to lipohyalinosis from hypertension, but also may arise 
because of atheromatous disease at their origin. Occasionally, recurrent stereotyped TIAs 
occur; in this setting, the term lacunar or small vessel TIAs seems appropriate. 
CLINICAL MANIFESTATIONS —  The symptoms of a transient ischemic attack 
(TIA) depend upon the pathophysiologic subtype. 
Low-flow TIA — Low-flow TIAs usually are short-lived (minutes) and often recurrent. 
They may occur as little as several times per year but typically occur more often (once 
per week or up to several times per day). 
Low-flow TIAs are generally stereotyped, especially when they are due to 
hemodynamically significant stenotic lesions at the origin of the internal carotid artery, at 
the siphon portion of the internal carotid artery where collateral flow to the circle of 
Willis is inadequate, or in the middle cerebral artery stem. Symptoms due to ischemia 
from these lesions often include hand, arm, leg, face, tongue, or cheek numbness or 
weakness together, or a combination of one or more. Recurrent aphasic syndromes appear 
when there is focal ischemia in the dominant hemisphere, and recurrent neglect occurs in 
the presence of focal or nondominant hemisphere ischemia. 
In contrast, recurrent symptoms are often not stereotyped when the stenotic lesion that 
obstructs flow involves the vertebrobasilar junction or the basilar artery. The many 
closely packed neuronal structures in the brainstem preclude consistent manifestations of 
recurrent focal ischemia in this area. 
Nevertheless, certain generalizations about recurrent low-flow TIA symptoms in the 
posterior circulation can be made. Obstructive lesions in the distal vertebral artery or at 
the vertebrobasilar junction usually cause disorganized dizziness that may or may not 
include spinning or vertigo. The patient may complain that the room is tilting or that the 
floor is coming up at them, rather than spinning dizziness. Patients most often use the 
word dizziness to describe a myriad of symptoms, not necessarily spinning. Other 
symptoms may include numbness of one side of the body or face, dysarthria, or diplopia. 
Ischemia in the pons from stenotic lesions in the proximal to midbasilar artery can cause 
bilateral leg and arm weakness or numbness and a feeling of heaviness in addition to 
dizziness. Patients often say it feels as though all of their energy has been drained. They 
may speak of a feeling of impending doom. Ischemia in the territory of the top of the 
basilar artery or proximal posterior cerebral artery may present with all of the above 
recurrent symptoms as well as overwhelming drowsiness, vertical diplopia, eyelid 
drooping, and an inability to look up. Transient ischemia at the top of the basilar artery is 
usually due to embolism rather than low-flow TIA.  
Embolic TIA — Embolic TIAs typically last hours rather than minutes as in low-flow 
TIAs. They may be infrequent since they are the result of emboli from a specific source 
(eg, a one, two, or three-time phenomenon). When the source of the embolus is in a 
proximal vessel, recurrent emboli can lodge in different branches of the parent vessel 
giving different symptoms. 
Emboli are subject to natural thrombolysis and migration since they typically break off of 
fresh thrombus. They may produce transient ischemia on many occasions, but an element 
of silent infarction remains. Emboli may be better referred to as acceptable minor 
embolism (ACME), a term coined by C Miller Fisher. 
Embolic TIAs are best divided into those in the anterior cerebral circulation (carotid, 
ACA, MCA territory) and those in the posterior cerebral circulation (vertebrobasilar, 
posterior cerebral artery territory). Symptoms in both circulations depend upon the size of 
the embolic fragment in relation to the size of the artery occluded. 
Embolic TIAs in the anterior circulation may be large enough to occlude the middle 
cerebral artery stem, producing a contralateral hemiplegia secondary to ischemia in the 
deep white matter and basal ganglion/internal capsule lenticulostriate territory (figure 6). 
In addition, they may produce cortical surface symptoms when pial collateral flow is 
inadequate. These include aphasic syndromes in the dominant hemisphere and 
anosognosia or neglect in the nondominant hemisphere. 
Smaller emboli that occlude branches of the middle cerebral artery stem result in more 
focal symptoms, including hand alone or arm and hand numbness, weakness, and/or 
heaviness induced by ischemia to the frontal area of the contralateral frontal lobe motor 
system (figure 4). The symptoms also may be as specific as thumb or hand numbness or a 
swollen feeling, suggesting focal ischemia in the hand area of the sensory strip or parietal 
association cortex. Transient unilateral visual obstruction often signifies atherothrombotic 
disease in the internal carotid artery proximal to the ophthalmic artery takeoff. 
Atherothrombotic disease is most often responsible for these syndromes, although carotid 
dissection and embolism from the aorta, heart, or an unknown source also should be 
considered. 
Posterior circulation territory embolic TIAs are generally produced by emboli arising 
from atherothrombotic disease at the origin or distal segment of one of the vertebral 
arteries or of the proximal basilar artery. Emboli arising from the aortic arch, the heart, an 
unknown source, or from a dissecting lesion in the vertebral artery should also be 
considered. 
Symptoms vary according to the vertebral or basilar artery branch in which the emboli 
lodges (figure 7). Emboli can produce transient ataxia, dizziness, diplopia, dysarthria, 
quadrantanopsia, hemianopsia, numbness, crossed face and body numbness, and focal 
hearing loss. When the top of the basilar artery is embolized, sudden, overwhelming 
stupor or coma may ensue due to bilateral medial thalamic, subthalamus, and medial 
rostral midbrain reticular activating system ischemia. Emboli in the more distal branches 
of the posterior cerebral artery may result in a homonymous field defect or in memory 
loss (inferior medial temporal lobe ischemia). 
Lacunar or small vessel TIA — Lacunar or small vessel TIAs are thought to be caused 
by atherothrombotic obstructive lesions at the origin of the penetrating vessel or 
lipohyalinosis distally. Embolism is rarely proposed as the mechanism. These small 
vessel TIAs cause symptoms that are similar to the lacunar strokes that are likely to 
follow. Thus, face, arm, and leg weakness or numbness due to ischemia in the internal 
capsule, pons, or thalamus may occur, similar to the symptoms due to ischemia from 
embolism or large vessel atherothrombotic disease or dissection. As a result, serious 
disease in the parent vessel must be excluded before the diagnosis of lacunar or small 
vessel TIA can be established with confidence. 
Lacunar infarcts may be preceded by lacunar TIAs consisting of brief repetitive 
stereotyped clinical symptoms and signs, and lacunar stroke onset may be stepwise and 
progressive rather than abrupt [23-25]. Such a pattern of TIAs, or nonsudden onset in 
association with a lacunar syndrome, is highly suggestive of small vessel lipohyalinotic 
etiology [26]. 
IMPORTANT PATHOLOGIC PROCESSES — There are four pathologic processes 
that give rise to low-flow "true" TIAs or embolic TIAs and that can produce sudden 
devastating stroke if not recognized and treated. Atherothrombotic stenotic lesions at the 
origin of the internal carotid artery that are narrowed more than 70 percent Intracranial 
atherothrombotic disease that produces low-flow or embolic TIA due to lesions at the 
distal vertebral artery/vertebrobasilar junction/proximal basilar artery Emboli to the top 
of the basilar artery or the middle cerebral artery stem that come from a source below, 
either arterial, aortic, or cardiac Dissection lesions at the origin of the petrous portion of 
the internal carotid artery or at the C1-2 level of the vertebral artery as it enters the 
foramen transversarium  
Internal carotid artery TIA — An atherothrombotic stenotic lesion at the origin of the 
internal carotid artery that is narrowed to more than 70 percent of its normal lumen 
diameter poses a threat of embolic or low-flow TIA or stroke [27-30]. Even a 50 percent 
stenosis may be important when considering carotid endarterectomy for prevention of a 
secondary stroke or of a primary stroke when a TIA has occurred.  
Prospective natural history studies of asymptomatic atherothrombotic disease at the 
origin of the internal carotid artery (mostly asymptomatic carotid artery bruits) suggest 
that the rate of ipsilateral stroke increases dramatically when the residual lumen diameter 
narrows to greater than 70 percent stenosis (figure 8 and figure 9) [31-33]. In one series 
of 500 patients, for example, the incidence of stroke was 1.7 percent per year overall but 
5.5 percent per year in those with more than a 75 percent carotid artery stenosis [32]. 
This degree of stenosis corresponds to a residual lumen diameter of 1.5 mm, the precise 
point at which pressure drops across the stenotic lesion [34,35]. When the pressure drops, 
flow to the ipsilateral middle cerebral artery stem is in part supplied by collateral 
circulation from the circle of Willis and from the external carotid to ophthalmic to distal 
internal carotid artery system (figure 2 and figure 3). Less flow is provided by the internal 
carotid artery as the lesion further narrows. It is believed that this provides a milieu for 
thrombus formation at the site of the stenosis and subsequent embolism. When the circle 
of Willis is compromised, low-flow "true" TIA ensues. 
Intracranial atherothrombotic disease — Intracranial atherothrombotic disease that 
produces low-flow or embolic TIA most commonly occurs at the distal vertebral 
artery/vertebrobasilar junction/proximal basilar artery site. The potential of this lesion to 
precipitate a disastrous stroke by thrombosis, thrombus propagation, and embolism is 
extremely important. The other two most important, but less common, sites include the 
siphon portion of the internal carotid artery and the middle cerebral artery stem. The 
common carotid origin and the vertebral artery origin are much less problematic since 
they only rarely give rise to artery-to-artery emboli. 
The ability to noninvasively diagnose and follow these intracranial arterial lesions with 
precision through MRI angiography, duplex Doppler, and transcranial Doppler flow 
assessment allows for important preventive therapeutic considerations.  
Arterial, aortic, or cardiac sources of emboli — Emboli at the top of the basilar artery or 
in the middle cerebral artery stem that come from a source below — arterial, aortic, or 
cardiac — are extremely important to recognize since they may produce fluctuating 
symptoms or TIAs prior to a devastating stroke. Transient focal symptoms due to an 
embolus at these sites occur because blood flow reestablishes itself around the embolus. 
The symptoms may return in abundance and produce a stroke when the embolus itself 
causes a thrombus that further occludes the artery. This can occur hours or even days 
after the embolus has lodged at the site because it did not migrate or lyse. Acute 
antithrombotic therapy with heparin may be highly effective in preventing this thrombus 
propagation and provide the time for spontaneous thrombolysis, although this has not 
been proven definitively. 
Dissection lesions — Dissection lesions at the origin of the petrous portion of the internal 
carotid artery or at the C1-2 level of the vertebral artery as it enters the foramen 
transversarium cause symptoms of cerebral ischemia due to low flow or embolism, which 
occur within minutes, hours, or even days prior to a devastating stroke. Modern Doppler 
and neurologic imaging technology can establish the diagnosis noninvasively with the 
necessary precision to permit potentially stroke-saving therapeutic strategies (eg, 
intravenous heparin). 
 
 
 
 
 
 
 
 
 
 
 
                                        Figure 2. Anatomy of the cerebral arterial                            
 
  Coronal section of cerebral hemisphere 
 
                                                                                  
 
 
 
 
 
Figure 3.Representation of the territories of the major cerebral vessels circulation 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Middle cerebral artery distribution and signs and symptoms of occlusion 
Figure 5. Superior pontine syndrome 
  
Figure 6. Anterior cerebral artery distribution and signs and symptoms of occlusion 
 
  
Figure 7. Posterior cerebral artery distribution and signs and symptoms of occlusion 
Severity of carotid stenosis predicts stroke risk 
 
Figure 8. Relation between the degree of carotid artery stenosis and the annual risk of stroke. Data from Barnett, 
HJ, Eliasziw, M, Meldrum, HE, Taylor, DW, Neurology 1996; 46:603. 
 
Figure 9. Incidence of ischemic events in 500 patients with asymptomatic carotid artery bruits according to the 
severity of carotid artery stenosis on initial Doppler ultrasonography. Patients with 75 percent stenosis were at 
significantly increased risk (P<0.0001). Data from Chambers, BR, Norris, JW, N Engl J Med 1986; 315:860. 
 
Initial evaluation and management of transient ischemic attack and minor stroke 
INITIAL EVALUATION — Patients who have had a suspected TIA require urgent 
evaluation due to the high stroke risk associated with TIA [1]. Furthermore, immediate 
intervention after a TIA may prevent a significant number of strokes.  
The initial evaluation of suspected TIA and minor nondisabling ischemic stroke includes 
basic laboratory studies that are suggested by the history and physical examination, an 
electrocardiogram, brain imaging, and neurovascular imaging. Laboratory testing is 
helpful in ruling out metabolic and hematologic causes of neurologic symptoms, 
including hypoglycemia, hyponatremia, and thrombocytosis. 
Several neurologic disorders give rise to transient focal neurologic symptoms, and these 
should be considered before establishing a diagnosis of TIA. In addition to TIAs, the 
most important and frequent causes of discrete self-limited attacks include: Seizures 
Migraine auras Syncope  
Less frequent causes include pressure- or position-related peripheral nerve or nerve root 
compression that causes transient paresthesias and numbness; peripheral vestibulopathies 
that cause transient episodic dizziness; and metabolic perturbations such as hypoglycemia 
and hepatic, renal, and pulmonary encephalopathies that can produce temporary 
aberrations in behavior and movement.  
Hospitalization versus ambulatory evaluation — Whether hospitalization is required 
for TIA evaluation is not clear, but urgent assessment and management is essential 
regardless of inpatient or outpatient status [1, 35-39]. 
Possible advantages of hospitalization include facilitated early use of thrombolytic 
therapy and other medical management if symptoms recur, expedited TIA evaluation, and 
expedited institution of secondary prevention [39]. 
The 2009 American Heart Association and American Stroke Association (AHA/ASA) 
guidelines for the definition and evaluation of TIA state that it is reasonable to hospitalize 
patients with TIA who present within 72 hours of symptom onset and meet any of the 
following criteria [1] :  
• ABCD^2 score (show table 1) of ≥ 3  
• ABCD^2 score of 0 to 2 and uncertainty that the diagnostic workup can be 
completed within two days as an outpatient  
• ABCD^2 score of 0 to 2 and other evidence that the event was caused by focal 
ischemia  
The ABCD^2 score (ie, ABCD squared, for Age, Blood pressure, Clinical features, 
Duration of symptoms, and Diabetes) is a simple prognostic assessment tool with 
moderate predictive accuracy that was designed to identify patients at high risk of 
ischemic stroke in the first two days after TIA, as discussed later in detail (table 1).  
The 2006 National Stroke Association (NSA) guidelines systematically reviewed, 
critically evaluated, and updated prior published guidelines for the management of TIA 
[39]. The following consensus recommendations regarding initial management were 
proposed, based mainly on evidence from observational studies and clinical experience: 
Hospitalization should be considered for patients with a first TIA within the past 24 to 48 
hours, and is generally recommended for patients with the following conditions:  
   - Crescendo TIAs  
   - Duration of symptoms >1 hour  
   - Symptomatic internal carotid artery stenosis >50 percent  
   - Known cardiac source of embolus such as atrial fibrillation  
   - Known hypercoagulable state  
   - High risk of early stroke after TIA  
Patients who need urgent evaluation and are not hospitalized should have rapid access to 
the following studies:  
   - Brain imaging with head CT and/or MRI  
   - Neurovascular studies such as CT angiography (CTA), MR angiography (MRA), 
and/or ultrasound 
   - Electrocardiogram (ECG)  
All patients with a TIA within the past two weeks who are not hospitalized should 
undergo investigations within 24 to 48 hours to determine the mechanism of ischemia 
and subsequent preventive therapy Patients who are not admitted should be informed that 
they need to return to the hospital immediately if symptoms recur  
PROGNOSIS — TIA is a neurologic emergency because patients with TIA and minor 
stroke are at increased risk of recurrent stroke [40-47]. This risk is illustrated by the 
following studies:  
• A meta-analysis of 11 observational studies published through December 2006 
found that the risk of stroke at 2 days, 30 days, and 90 days after TIA was 3.5, 8.0, 
and 9.2 percent, respectively [45]. In the three studies that used active 
ascertainment of stroke outcome (ie, face-to-face evaluation by a practitioner at 
three months rather than use of administrative data), the 2, 30, and 90 day risk of 
stroke after TIA was even higher (9.9, 13.4, and 17.3 percent, respectively). 
Similar findings were reported in a meta-analysis of 18 cohorts published through 
June 2007 [48]. 
• A prospective observational study of 1380 patients with TIA and 3855 patients 
with ischemic stroke found that subsequent stroke incidence during the hospital 
stay was 8 percent for patients with TIA and 7 percent for patients with ischemic 
stroke [49]. During the first six months after the initial ischemic event, recurrent 
stroke incidence was 13 percent for both groups. Two percent of patients with TIA 
died during hospital stay, and 17 percent were dependent at follow-up.  
• A well-designed prospective cohort study of 2447 participants from the Dutch TIA 
trial found that the risk for major vascular events and stroke was highest shortly 
after TIA or minor stroke, declined to its lowest point at about three years, and 
then progressively increased over the remainder of the 10-year follow-up (figure 
10) [50]. In contrast, the risk for mortality gradually rose throughout the study. By 
10 years, 60 percent had died and 54 percent had experienced new vascular events 
(stroke and myocardial infarction). Event-free survival was 48 percent. Predictive 
factors for risk of vascular events and death included age over 65 years, diabetes, 
claudication, previous vascular surgery, and pathologic Q waves on baseline 
electrocardiogram.  
The urgency associated with TIA derives also from the observation that TIAs are most 
likely to occur in the hours and days immediately preceding ischemic stroke. As an 
example, a study that analyzed four cohorts of patients who had recent ischemic stroke 
found that TIAs occurred most often in the 48 hours prior to the stroke [51]. Another 
study found that the risk of ischemic stroke occurring within 24 hours of a probable or 
definite TIA was approximately 5 percent [52]. Of all ischemic strokes during the 30 
days after a first TIA, 42 percent occurred within the first 24 hours. This may be an 
overestimate related to the difficulty distinguishing a single ischemic event (stroke) with 
fluctuating symptoms from separate events (TIA followed by stroke) within a short 
period of time. Nevertheless, these observations underscore the high early risk of 
developing a permanent deficit after transient ischemic symptoms and the importance of 
urgent assessment, risk stratification, and treatment. 
Given this short time window and high risk of stroke — 4 to 10 percent in the first 48 
hours after TIA [45] — neurologic evaluation of and intervention for TIA should occur 
urgently. Furthermore, clinical TIAs associated with evidence of infarction by 
neuroimaging may be a marker of particularly high risk for ischemic stroke.  
Recognition and urgent evaluation of TIAs can identify patients who may benefit from 
preventive therapy or from revascularization of large vessels such as the carotid artery. 
As examples, premonitory carotid territory TIAs occur in approximately 50 to 75 percent 
of patients with ischemic stroke from extracranial carotid disease [53-55],and 
vertebrobasilar TIAs are associated with a risk of subsequent stroke or death that is 
similar to or possibly higher than that seen with carotid TIAs [56]. In addition, the large 
artery atherosclerosis subtype of TIA appears to be associated with a higher risk of stroke 
recurrence at 7 and 90 days after TIA than other subtypes (cardioembolism, small vessel 
disease, undetermined, or other determined cause) [57]. 
Predicting stroke risk after TIA — Methods that can reliably assess the risk of stroke 
after TIA in individual patients would be useful for triaging patients. 
Preliminary evidence suggests that a simple assessment called the ABCD2 score (ie, 
ABCD squared, for Age, Blood pressure, Clinical features, Duration of symptoms, and 
Diabetes) can be used to identify patients at high risk of ischemic stroke in the first two 
days after TIA [58]. The ABCD2 score is tallied as follows:  
• Age (≥ 60 years = 1 point)  
• Blood pressure elevation when first assessed after TIA (systolic ≥ 140 mmHg or 
diastolic ≥ 90 mmHg = 1 point)  
• Clinical features (unilateral weakness = 2 points; isolated speech disturbance = 1 
point; other = 0 points)  
• Duration of TIA symptoms (≥ 60 minutes = 2 points; 10 to 59 minutes = 1 point; 
<10 minutes = 0 points)  
• Diabetes (present = 1 point)  
The ABCD2 score was based upon two earlier prognostic scores for TIA — the California 
score [43] and the ABCD score [59] — and was derived and validated using independent 
study populations (two derivation and four validation cohorts) from the US (California) 
and the UK (Oxford) that included 4809 patients with TIA [58]. The new unified 
ABCD^2 score was a slightly more accurate predictor of stroke risk than either of its 
predecessors in these populations. 
Estimated two-day stroke risks determined by the ABCD2 score in the combined 
derivation and validation cohorts were as follows [58] : Score 6 to 7: High two-day stroke 
risk (8.1 percent) Score 4 to 5: Moderate two-day stroke risk (4.1 percent) Score 0 to 3: 
Low two-day stroke risk (1.0 percent)  
No patient in any of the cohorts with an ABCD2 score of ≤ 1 had a stroke within two days 
[58]  
This study supports the idea that TIA is a high-risk condition and that, in the right clinical 
context, prognostic scores may identify individuals who are most likely to have an 
imminent stroke [58]. 
While the ABCD2 score may be a useful clinical tool, its predictive performance was 
generally lower in hospital settings (where clinical decisions are resource intensive or 
involve risk) compared with population based settings, potentially limiting its utility [58]. 
In addition, there was considerable variation in the stroke risk associated with higher 
ABCD2 scores among the six population cohorts in which the score was tested. Of 
concern, a retrospective population-based study found that patients classified as low risk 
by an ABCD2 score ≤ 4 had a higher rate of stroke (6 percent) within seven days of TIA 
than low risk patients in the initial report (1 percent) [60]. Twenty-five percent of 
subsequent stroke events occurred in patients with scores ≤ 4. 
Risk models that combine information from acute diffusion-weighted MRI and presumed 
TIA etiology in addition to the clinical ABCD2 score may improve the accuracy of stroke 
risk prediction after TIA [61,62]. As an example, the CIP model incorporated diffusion-
weighted MRI findings with a dichotomized ABCD2 score [61]. The result was improved 
accuracy, compared with the ABCD2 score alone, for stroke risk predictions at both two 
days and seven days after TIA. However, the absence of external validation and the 
requirement for MRI limit the widespread applicability of this model. 
In conclusion, further refinement and validation of stroke risk scores in diverse settings is 
needed before making clear-cut recommendations based on these scores. Until then, rapid 
etiologic evaluation and institution of secondary preventive measures are essential for all 
patients with TIA. 
URGENT TREATMENT — The preferred approach to treatment of TIA and ischemic 
stroke is to determine the pathophysiology of the event so that specific stroke preventive 
therapy can be prescribed. An overview of the treatment of specific causes of TIA and 
ischemic stroke is discussed elsewhere. In addition to specific treatment, accumulating 
evidence suggests that immediate intervention after a TIA or minor ischemic stroke can 
reduce the risk of recurrent stroke compared with delayed intervention. This point is 
illustrated by the following reports:  
• The prospective EXPRESS study evaluated the impact of expediting outpatient 
treatment for TIA or minor ischemic stroke [63]. In order to compare traditional 
with expedited treatment, the study was conducted in two phases. In phase one, 
323 patients were seen in a traditional clinic setting where evaluation required a 
scheduled appointment and treatment recommendations were made to referring 
physicians. In phase two, 297 patients were seen in an urgent walk-in stroke clinic 
without having to arrange an appointment, and treatment was implemented 
immediately by clinic practitioners. In both phases, treatment of confirmed TIA or 
stroke was individualized according to patient characteristics, but generally 
included antiplatelet or anticoagulant therapy, statin therapy, antihypertensive 
medication, and carotid endarterectomy as required.  
The following observations were reported [63] : 
   - The median delay to assessment in the outpatient clinic was significantly reduced 
from phase one to phase two (3 days versus <1 day), as was the median delay to first 
prescription of treatment (20 days versus 1 day) 
   - The risk of recurrent stroke at 90 days was significantly lower for patients seen in 
phase two than for those seen in phase one (2.1 versus 10.3 percent; adjusted hazard ratio 
0.20, 95% CI 0.08-0.49) 
Although EXPRESS was not a randomized trial, the study was nested in an ongoing 
population-based study of stroke and TIA, thus minimizing the potential problems of 
incomplete ascertainment and selection bias that complicate observational studies.  
• The observational SOS-TIA study analyzed the rapid assessment of 1085 patients 
with suspected TIA in a hospital-based clinic with 24 hour access [64]. Patients 
were evaluated within four hours of admission, and those with a final diagnosis of 
confirmed or possible TIA (n = 845) received immediate treatment with a stroke 
prevention program that included antiplatelet or anticoagulant treatment and/or 
carotid revascularization as appropriate. At 90 days, the observed stroke rate was 
much lower than an expected stroke rate predicted by the ABCD^2 scores (1.24 
versus 5.96 percent).  
The results of this study should be interpreted with caution because of methodologic 
limitations, including the use of ABCD^2 scores to predict stroke risk, rather than 
determination of stroke risk in a control population [65]. 
Early evaluation and intervention for symptomatic carotid artery disease may be an 
important aspect of stroke prevention. Supporting evidence comes from a pooled analysis 
of the NASCET and ECST trials, which found that early carotid endarterectomy (within 
two weeks of a nondisabling stroke or TIA) significantly improved outcome compared 
with later surgery [66]. Thus, early identification of symptomatic carotid disease is 
critical.  
Given these data, it is recommend that appropriate diagnostic evaluation and stroke 
prevention treatment be implemented without delay, preferably within one day of the 
ischemic event, for patients who present with TIA or minor ischemic stroke. 
 
Figure 10. Development of yearly risks over time after TIA or minor stroke. Long-term 
survival and vascular events risk after transient ischaemic attack or minor ischaemic 
stroke: a cohort study. Lancet 2005; 365: 2098. Copyright © 2005 Elsevier. 
 
 
 
 
Table 1. ABCD2 score. 
The ABCD 2 score can be used to identify patients at high risk of ischemic stroke in the first two 
days after TIA. The score is tallied as follows: 
Age: 
60 years 1 point 
<60 years 0 points 
Blood pressure elevation when first assessed after TIA: 
Systolic 140 mmHg or diastolic 90 mmHg 1 point 
Systolic <140 mmHg and diastolic <90 mmHg 0 points 
Clinical features: 
Unilateral weakness 2 points 
Isolated speech disturbance 1 point 
Other 0 points 
Duration of TIA symptoms: 
60 minutes 2 points 
10 to 59 minutes 1 point 
<10 minutes 0 points 
Diabetes: 
Present 1 point 
Absent 0 points 
 
Data from: Johnston, SC, Rothwell, PM, Nguyen-Huynh, MN, et al. Validation and refinement of scores to predict 
very early stroke risk after transient ischaemic attack. Lancet 2007; 369:283. 
Materials and Methods 
Methodology 
This study was a longitudinal, prospective, observational study. 
Sample Size 
         We prospectively analyzed 249 consecutive patients with TIAs who were referred 
to our out-patient department within 72 hrs of TIA onset between Oct 2007 and March 
2010. Of these, 36 patients were excluded as they did not meet inclusion criteria while 7 
patients were excluded because of improper documentation. In effect we could analyze 
206 patients. Of these 116 were men and 90 women with a mean age of 54.4 ± 10.1 
years. A diagnosis of TIA was made in cases of clinical deficits lasting less than 24 hours 
regardless of an infarction seen on cerebral imaging scans. ABCD2 scoring of all patients 
was recorded at the time of their first visit. Computed tomography (CT) was performed 
on all patients within two weeks of onset of the TIA in order to exclude nonischemic 
brain lesions such as brain hemorrhage, chronic subdural hematoma, and brain tumors. 
All patients were followed up for a minimum period of 90 days. 
 
 
 
Methods 
Inclusion Criteria 
Patients referred to Neurology OPD with reversible episodes of neurologic deficits of 
vascular origin that resolve completely within 24 hours. 
Exclusion Criteria 
1. Seizures at onset 
2. Severe Cognitive impairment 
3. Signs and symptoms not consistent with neuroanatomical and vascular distribution 
 
Hospitalization: According to 2006 National Stroke Association (NSA) guidelines, 
patients with crescendo TIAs, duration of symptoms >1 hour, symptomatic internal 
carotid artery stenosis >50 percent, known cardiac source of embolus such as atrial 
fibrillation, known hypercoagulable state, high risk of early stroke after TIA were 
admitted and these patients received a five day course of subcutaneous heparin in 
addition to aspirin and statin. 
         Information on symptoms during the TIAs was obtained from the patients or their 
families. The presence or absence of the following symptoms was assessed: disturbance 
of consciousness, speech disturbance, nausea/vomiting, vertigo/dizziness, visual 
disturbance, motor weakness, sensory disturbance, and gait disturbance. If a patient had a 
speech disturbance, a careful history was taken so as to distinguish aphasia from 
dysarthria. 
        The following baseline and clinical characteristics were evaluated: 1) age and 
gender: 2) duration of TIA (<1 hour, and 1-24 hours): 3) number of TIAs: 4) use of 
antiplatelet agents or anticoagulants: 5) past history of brain infarction, TIA, myocardial 
infarction, or definite angina pectoris: 6) risk factors for stroke, including hypertension, 
diabetes mellitus, hyperlipidemia, and current smoking: 7) significant arterial pathologies 
in the carotid system: and 8) potential cardiac source of emboli. 
The criteria for stroke risk factors were as follows: 1) use of antihypertensive agents, 
systolic blood pressure (SBP) >160 mm Hg or diastolic blood pressure (DBP) >90 
mmHg: 2) use of oral hypoglycemic agents, insulin, or glycosylated hemoglobin 
(HbA1C) >6.4%: 3) use of antihyperlipidemic agents, or serum cholesterol level >200 
mg/dl and serum triglyceride level 150 mg/dL: and 4) current smoking defined as a 
history of smoking in the preceding three months. Information on risk factors and other 
comorbidity was obtained primarily from the patient; additional information was 
collected from relatives. All patients gave in-formed consent and follow-up was by either 
direct interview or through mobile phone. Patients were directly followed up on 2nd, 7th, 
30th, and 90th day. 
ABCD2 score (ie, ABCD squared, for Age, Blood pressure, Clinical features, Duration 
of symptoms, and Diabetes) was used to identify patients at high risk of ischemic 
stroke. The ABCD2 score is tallied as follows:  
• Age (≥ 60 years = 1 point)  
• Blood pressure elevation when first assessed after TIA (systolic ≥ 140 mmHg or 
diastolic ≥ 90 mmHg = 1 point)  
• Clinical features (unilateral weakness = 2 points; isolated speech disturbance = 1 
point; other = 0 points)  
• Duration of TIA symptoms (≥ 60 minutes = 2 points; 10 to 59 minutes = 1 point; 
<10 minutes = 0 points)  
• Diabetes (present = 1 point)  
For study purpose the patients were grouped according to: 
 1) duration of TIAs into intervals of less than 10 minutes, 10 minutes to less than 2 
hours, and 2 hours to less than 24 hours  
2) the etiological classification, they were subsequently grouped as Atrial Fibrillation and 
Non-Atrial Fibrillation groups. 
3) the presence or absence of CT findings in patients with no prior history of stroke. 
4) treatment, as heparin and non heparin groups 
     To detect potential cardiac sources of emboli (emboligenic cardiac diseases), all 
patients underwent 12-lead electrocardiography (ECG) and transthoracic 
echocardiography. AF included both paroxysmal and persistent AF and was identified 
during hospitalization. Emboligenic cardiac diseases included non-valvular AF: acute 
myocardial infarction, old myocardial infarction with intraventricular thrombus: mitral 
valve disease: prosthetic cardiac valve: implantation of a pacemaker: and dilated 
cardiomyopathy. 
We performed color-flow duplex ultrasonography in all patients in order to evaluate 
significant arterial pathologies in the carotid and vertebral system. The grade of stenosis 
of the internal carotid artery (ICA) was determined by the method used in the North 
American Symptomatic Carotid Endarterectomy Trial. The lesions were considered 
significant if the ICA showed >70% stenosis or if an ulceration was evident in the carotid 
bifurcation. 
Ethics 
Data for the study was collected following the local ethical guidelines. The identity of the 
individual patients was completely anonymous. All patients signed an informed consent. 
There was no delay in any of the therapeutic interventions in order to carry out the 
present study. 
Statistical Analysis 
Statistical analysis was performed using PASW version 18.0 statistical software (SPSS 
Inc, Chicago, Ill). P values <.05 was considered statistically significant. 
 
 
 
 
Results 
AGE DISTRIBUTION:  
    The maximum number of patients were in the age group between 50 and 59 years 
followed by the age group between 40 and 49, 60 and 69 years. Table 1 shows the age 
distribution in this study.  
TABLE - 1: AGE DISTRIBUTION 
Age group in years No. of Patients  % of Total Patients (206) 
<40 23 11.17 
40 – 49 52 25.23 
50 – 59 74 35.92 
60 – 69 49 23.78 
> 70 8 3.9 
Total 206 100 
 
SEX DISTRIBUTION:  
There were 116 males (56.3%) and 90 females (43.7%) among the 206 patients in this 
study. 
 
 
         TABLE 2: SEX DISTRIBUTION IN THIS STUDY 
Sex No. of Patients  % of Total Patients (206) 
Males 116 56.3 
Females 90 43.7 
Total 206 100 
 
AGE AND SEX DISTRIBUTION: 
Males predominated in the age group between 50 and 59 years followed by 40 to 49 
years. Females predominated in the age group between 50 and 59 years followed by 60 to 
69 years.  
Around two thirds of males (70.7%) were in the age group between 40 and 59 years and 
two-third of females (61.1%) were in the age group between 50 and 69 years. The Table 
3 shows age distribution based on sex. 
TABLE 3: AGE DISTRIBUTION BASED ON SEX 
Age Group in Years Males (116) Females (90) 
<40 13 (11.2%) 10 (11.1%) 
40 – 49 31 (26.7%) 21 (23.4%) 
50 – 59 41 (35.4%) 33 (36.7%) 
60 – 69 27 (23.2%) 22 (24.4%) 
> 70 4 (3.5%) 4 (4.4%) 
Total 116 (100%) 90 (100%) 
RISK FACTORS 
 HYPERTENSION:  
Among 206 patients, 129 patients had hypertension (62.6%) 
   TABLE -4: PREVALENCE OF HYPERTENSION IN THIS STUDY 
Duration in years No. of patients % of total Patients (206) 
Detected now 21 10.2 
0 - 1 year 22 10.8 
1 - 5 years 43 20.8 
> 5 years 43 20.8 
Total 129 62.6 
 
DIABETES: 
Out of 206 patients, 92 patients were diabetic (44.6%) 
   TABLE -5: PREVALENCE OF DIABETES MELLITUS IN THIS STUDY 
Duration No. of patients % of Total Patients (206) 
Detected now 9 4.36 
0 - 1 years 14 6.77 
1 - 5 years 29 14.07 
> 5 years 40 19.4 
Total 92 44.6 
 
 
 SMOKING: 
93 patients were smokers (45.1%), (91 males and 2 females). 
  TABLE -6: PROPORTION OF SMOKING IN THIS STUDY 
Duration No. of patients % of Total Patients (206) 
0 - 5 years 7 3.4 
5 - 10 years 16 7.8 
> 10 years 70 33.9 
Total 93 45.1 
 
 ALCOHOLISM: 
  73 patients were alcoholic (35.4%) (67 were males, 6 were females). 
 TABLE -7: PREVALENCE OF ALCOHOL INTAKE IN THIS STUDY 
Duration No. of patients % of Total Patients (206) 
0 - 5 years 5 2.4 
5 - 10 years 17 8.25 
> 10 years 51 24.75 
Total 73 35.4 
 
 
 
 
SERUM LIPID PROFILE: It was done in all patients.  
TOTAL CHOLESTEROL (TC): 
   TABLE -8: RANGE OF TOTAL CHOLESTEROL VALUES IN THIS STUDY 
TC  range (mg/dl) No. of Patients % of total Patients (206) 
< 150 33 16 
150 – 199 89 43.2 
200  – 249 44 21.4 
> 250 40 19.4 
Total 206 100 
Above cut off in 40% 
TRIGLYCERIDES: 
    TABLE - 9: RANGE OF TRIGLYCERIDES VALUES IN THIS STUDY 
TGL range No. of Patients % of total Patients (206) 
< 150 29 14.02 
150 – 199 75 36.5 
200 – 399 101 49 
> 400 1 0.48 
Total 206 100 
 HDL CHOLESTEROL: 
  TABLE -10: RANGE OF HDL CHOLESTEROL VALUES IN THIS STUDY 
HDL range (mg/dl) No. of Patients % of total Patients (206) 
> 40 84 40.77 
< 40 122 59.23 
Total 206 100 
 
ECHO CARDIOGRAPHY: 
It was done in all patients (206) (Table: 11) 
Echo No % of total Patients (206) 
LVH with Normal EF 120 58.4 
Normal study 28 13.6 
LV systolic dysfunction 31 15 
LV Global dysfunction 2 0.96 
Rheumatic Heart disease 9 4.3 
MVPS with MR 1 0.48 
MVPS without MR 9 4.3 
LA clot 4 1.9 
Aortic valve sclerosis 1 0.48 
Prosthetic valve 1 0.48 
Total 206 100 
  
CLINICAL FEATURES: 
The clinical features of all the patients were studied in detail. The commonest 
presentation was the weakness of the extremities with or without speech, language, 
sensory and gait disturbances. 
MOTOR WEAKNESS: 
It was the commonest clinical presentation and seen in 135 patients among the 206 
patients (65.53%) in this study. Among the 135 patients, Right side weakness was found 
in 53 patients (25.72%) and Left side weakness was seen in 82 patients (39.81%). 
TABLE - 12: DISTRIBUTION OF WEAKNESS 
Side of weakness No. of Patients % of total Patients (206) 
Right  53 25.72 
Left 82 39.81 
Total 135 65.53 
 
In addition, facio brachial monoparesis was seen in 15 patients, of which 13 were right 
sided and 2 were left sided. 
APHASIA: 
Aphasia was seen in 33 patients among the 206 patients (16.2%). Of these 33 patients, 21 
patients (66.6%) had right side weakness and 3 patients (9.1%) had left side weakness. 
Aphasia as the only clinical manifestation was seen in 4 patients while 5 patients had 
other symptoms in addition to aphasia 
DYSARTHRIA: 
Among the 206 patients in this study, 51 patients had dysarthria. 
   TABLE -14: DISTRIBUTION OF DYSARTHRIA 
 No. of Patients  % of total Patients (206) 
Anterior Circulation 26 12.6 
Post Circulation 25 12.1 
Total 51 24.7 
SENSORY DISTURBANCE: 
It was seen in 30 patients out of the 206 patients (14.56%). Table 14 shows the 
distribution of sensory disturbance in this study. Sensory disturbance as the only 
symptom occurred in 2 patients. 
 TABLE -15: DISTRIBUTION OF SENSORY DISTURBANCE 
Side of sensory disturbance No. of Patients % of total Patients (206) 
Right side 14 6.8 
Left side 16 7.76 
Total 30 14.56 
OTHER CLINICAL FEATURES:  
   TABLE -15: DISTRIBUTION OF OTHER CLINICAL FEATURES 
S.No Clinical features No. of Patients % of total Patients (206) 
1.  Visual Disturbance 17 8.25 
2.  Nausea & Vomiting 18 8.7 
3.  Dizziness/Vertigo 25 12.1 
4.  Gait Disturbance 48 23.3 
5.  LOC 38 18.4 
6.  Headache 6 2.9 
7.  TIA in the past 67 28 
8.  Stroke in the past 43 20.8 
 
TERRITORIAL DISTRIBUTION: TABLE – 16 
135 out of 206 (55.82%) patient had symptoms related to carotid territory while 63 
(30.58%) had symptoms of vertebrobasilar territory. 8 patients (3.38%) had mixed 
symptoms. While territory was uncertain in 20 (9.72%) 
Territory No. of patients % of total Patients (206) 
Carotid 115 55.82 
Vertebrobasilar 63 30.58 
Mixed 8 3.88 
Uncertain 20 9.72 
Total 206 100 
 
DURATION OF SYMPTOM: 
The symptom duration was reported as follows: <10 minutes in 64 patients, ≥ 10 and <30 
minutes in 21, ≥ 30 and <60 minutes in 17, ≥ 1 and < 2 hours in 31, ≥ 2 and < 12 h 30 in 
30, and ≥ 12 hours in the remaining 43 patients. In effect 64 patients had symptoms 
lasting < 10 min, 38 had symptoms between 10 and <60 minutes while 104 patients had 
symptoms lasting > 60 minutes. There was no significant difference between short 
duration (< 60 min, 102 patients) and long duration (> 60 min, 104 patients) TIAs in 
terms of the proportion. For this study we classified the patients into three groups for 
further analysis: 64 patients with TIAs <10 minutes (Group 1); 69 patients with TIAs ≥10 
minutes and < 2 hours (Group 2); and 31 patients with TIAs ≥ 2 hours (Group 3). 
DEMOGRAPHIC CHARACTERISTICS, COMORBIDITY, AND RISK 
FACTORS WITH RESPECT TO DURATION OF SYMPTOM: TABLE - 17 
Group 1 
<10 min 
(n=64) 
Group 2 
>10 min 
to <2 h 
(n=69) 
Group 3  
2 h to 
<24 h 
(n=73) 
 
Total 
(n=206) 
 
P 
value 
Age, Years 57.2 58.1 58.7 58 0.521 
Sex, M %  
56.25 (36) 53.6 (39) 56.1 (41) 55.1 (116) 0.993 
Prior TIA 
36 (23) 21.8 (15) 26 (19) 28 (67) 0.002 
Prior stroke 
9.3 (6) 20.2 (14) 31.5 (23) 20.8 (43) 0.0153
Atrial fibrillation 
4.6 (3) 8.7 (6) 20.5(15) 11.7 (24) 0.039 
Arterial hypertension 
64 (41) 60.8 (42) 63 (46) 62.6 (129) 0.86 
Hypercholesterolemia 
43.6 (28) 37.2 (26) 39.5 (30) 40.7 (84) 0.653 
Diabetes mellitus 
43.7 (28) 47.8 (33) 42.4 (31) 44 (92) 0.895 
Smoking 
43.7 (28) 46.3 (32) 46.5 (34) 45.1 (93) 0.788 
Cardiac Disease 
20.3 (13) 24.6 (17) 21.9 (16) 22.3 (46) 0.68 
Arterial disease 
6.2 (4) 5.7 (4) 6.8 (5) 6.3 (13) 0.986 
 All values in percentage. Values in bracket are absolute numbers. 
A history of cerebral infarction, atrial fibrillation was found more frequently in Groups 2 
and 3 than it was in Group 1. While history of prior TIA was more frequent in Group 1. 
No other differences in history or risk factors were observed among the three groups 
(table 16).  
 
 
 
DEMOGRAPHIC CHARACTERISTICS, COMORBIDITY, AND RISK 
FACTORS WITH RESPECT TO ETIOLOGY: TABLE - 18 
AF Group 
(n=24) 
Non-AF 
Group (n=182) 
P 
Value 
Age, years 59.7 56.3 0.015 
Sex, M (%) 56.2 54.4 0.834 
TIA Duration 
<1 hours 
1 to 24 hours 
12 90 
0.971 
12 92 
Number of TIAs 
1 
2 to 3 
4 to 9 
20 116 
0.267 
4 40 
0 26 
Medication at TIA, 
Antiplatelet 
Anticoagulation 
4 44 
0.538 
4 4 
Past History 
TIA 
Brain Infarction 
Angina 
Myocardial Infarction 
8 59 
0.419 
8 69 
0 13 
0 9 
Risk Factor 
Arterial hypertension 
Hypercholesterolemia 
Diabetes mellitus 
Smoking 
12 117 
0.32 
6 78 
4 88 
12 79 
Arterial Disease 4 86 
0.032 
Embologenic Cardiac Diseases other 
than AF 
RHD, MVP others 
0 24 
0.078 
 
Twenty four patients had AF (the AF group) and 182 did not have AF (non-AF group). 
Table 1 shows the clinical characteristics of these two groups. The mean of age in the AF 
group was higher than in the non-AF group (p=0.015). No significant differences 
between the two groups were observed in the duration or number of TIAs, use of 
medication, past history, or risk factors. Arterial diseases were seen more frequently in 
the non-AF group than in the AF group 53% vs 17%, (p=0.028). Emboligenic cardiac 
diseases were observed in 48 (23%) patients: 24 patients had non-valvular AF, 9 had 
rheumatic heart disease, 10 had MVPS, 1had a prosthetic mitral valve, 1 had aortic valve 
sclerosis. Other than AF, there were no significant differences observed in emboligenic 
cardiac diseases between the two groups (Table 17).  
 
CLINICAL TIA SYMPTOMS OF THE 2 GROUPS: TABLE 19 
AF Group 
(n=24) 
Non-AF 
Group 
(n=182) 
P Value 
Consciousness disturbance 
(%) 25 (6) 17.5 (32) 
0.008 
Speech disturbance (%) 50 (12) 42.8 (72) 0 
Nausea/vomiting (%) 4.1 (1) 9.3 (17) 0.032 
Dizziness/vertigo (%) 8.3 (2) 12.6 (23) 0.022 
Visual disturbance (%) 8.3 (2) 8.2 (15) 0 
Motor weakness (%) 66.6 (18) 64.2 (117) 0.47 
Sensory disturbance (%) 12.5 (3) 14.8 (27) 0.18 
Gait disturbance (%) 29.1 (7) 22.5 (41) 0.042 
 All values in percentage. Values in bracket are absolute numbers. 
Consciousness disturbance (25% vs 17.5%; P = 0.008) and gait disturbance (29.1% vs 
22.5%; P =.042) were more frequent in the AF group than in the non-AF group, whereas 
nausea/vomiting (4.1% vs 9.3%; P = 0.032) and dizziness/vertigo (8.3% vs 12.6%; P 
=.022) were more frequent in the non-AF group than in the AF group. No differences in 
speech disturbance (50% vs 42.8%; P = 0), visual disturbance (8.3% vs 8.2%; P = 0), 
motor weakness (66.6% vs 64.2%; P = 0.47), and sensory disturbance (12.5% vs 14.8%; 
P = 0.18) were identified between the 2 groups. 
RECURRENT TIA 
               The proportion of patients with recurrent TIA was 34% (70 out of 206 patients) 
in our study. 44 patients (21.4%) had 2 to 3 TIAs while 26 patients (12.6%) had > 4 
TIAs. Of the recurrent TIAs 22 patients had stereotypical symptoms and most of them 
were of < 30 min. of the 48 patients with non –stereotypical TIAs, 32 had symptoms 
relating to vertebrobasilar territory. 
TRANSIENT SYMPTOMS WITH INFARCTION 
Of the 206 patient a total of 162 had TIA without prior history of stroke. 36 (22.2%) 
patients in this group had brain CT showing infarction. 
 
 
 
 
 
DEMOGRAPHIC CHARACTERISTICS, COMORBIDITY, AND RISK 
FACTORS WITH RESPECT TO BRAIN CT: TABLE – 20 
Sample 
Size 
CT 
showing 
Lesion 
(n=36) 
P Value 
Age  
<60 94 25.5 (14) 0.02 
>60 68 32.3 (22) 
Sex  
Male 92 27.1 (25) 0.125 
Female 70 15.7 (11) 
Prior TIA  
Yes 58  18.9 (11) 0.511 
No 104 24 (25) 
Arterial hypertension  
Yes 78 32 (25) 0.0105 
No 84 13.1 (11) 
Diabetes mellitus  
Yes 71 21.1 (15) 0.79 
No 91 23.1 (21) 
Smoking  
Yes 63 25.3 (16) 0.494 
No 99 20.2 (20) 
Prior Cardiovascular Disease  
Yes 36 22.2 (8) 1 
 No 126 22.2 (28) 
TIA Location  
Anterior 103 23.3 (24) 0.853 
Posterior 51 21.5(11) 
Both 8 12.5 (1) 
Stenosis  
Yes 68 30.8 (21) 0.0467 
No 94 16 (15) 
Symptom duration  
<1hr 56 17.8 (10) 0.392 
>1 hr 106 24.5 (26) 
 Of the 162 patients, 36 (22.2%) revealed cerebral infarctions, all of which were 
supratentorial. Infarcts were found in 25 men and 11 women. Small deep infarcts (basal 
ganglia and internal capsule, but none in the thalamus) were found in 12 patients, while 
19 had cortical or subcortical infarcts and 5 had multiple infarcts (4 with vertebrobasilar 
TIAs). Twenty-four carotid TIA patients had a cerebral infarct. In 17 of these the lesion 
was ipsilateral to the symptomatic hemisphere (although in 3 the symptoms did not 
correspond to the site of the infarct), while in 6 the lesion was contralateral and 1 patient 
had bilateral multiple infarcts. Eleven vertebrobasilar patients had infarcts. In 4, the 
infarct was in the posterior cerebral artery distribution causing visual disturbance. None 
of the other 7 vertebrobasilar TIA patients with infarcts had lesions correlated with the 
TIA. One patients with mixed TIAs had infarcts; and the lesion corresponded to the 
symptomatic  carotid  territory.  Thus,  of  all  162  patients,  23 (14.1%) had an infarction  
relating  to the TIA symptoms and 15 had  asymptomatic,  silent  infarcts.  (Two  patients  
had  both symptomatic and asymptomatic infarcts.) Age more than 60 and presence of 
stenosis were significantly associated with infarct on CT. There was no  significant 
difference in the  frequency of  infarction shown  by CT,  however,  between  carotid  and 
vertebrobasilar patients (P =  0.853), nor any significant associations  between  cerebral  
infarction and  gender, prior TIA, hypertension, diabetes mellitus, cardiac disease, or a 
past history of smoking. There was no significant association between duration of 
symptom and presence of infarction. 
ABCD2 SCORE: TABLE – 21 
ABCD2 Score Patients (%) 
<1 2 (1%) 
2 28 (13.5%) 
3 32 (15.5%) 
4 42 (20.5%) 
5 42 (20.5%) 
6 30 (14.5%) 
7 30 (14.5%) 
Total 206 (100%) 
 
GROUPING ACCORDING TO RISK: TABLE - 22 
ABCD2 Score No. of Patients % of total Patients (206) 
0 - 3 62 30.1 
4 – 5 84 40.8 
6 – 7 60 29.1 
Total 206 100 
 
62 (30.1%) patients were in low risk group, 84 (40.8%) in moderate risk, while 60 
(29.1%) were in high risk group 
 
 
 
 
 
 
ABCD2 SCORE AND THE RISK OF DEVELOPING STROKE AT 2, 7, 30 AND 
90 DAYS 
TABLE - 23 
ABCD2 
Score Patients (%) Stroke in 2 days 
% Risk (95% CI) 
<1 2 (1%) 0 0 
2 28 (13.5%) 0 0 
3 32 (15.5%) 0 0 
4 42 (20.5%) 1 2.4% (0 -6.99) 
5 42 (20.5%) 3 7.1% (0 – 14.93) 
6 30 (14.5%) 3 10% (0 – 20.74) 
7 30 (14.5%) 4 13% (1.17 – 25.49) 
Total 206 (100%) 11 (100%) 5.3% (2.27 – 8.41) 
 
TABLE - 24 
ABCD2 
Score Patients Stroke in 7 days 
% Risk (95% CI) 
<1 2 (1%) 0 0 
2 28 (13.5%) 0 0 
3 32 (15.5%) 0 0 
4 42 (20.5%) 1 2.4% (0 -6.99) 
5 42 (20.5%) 4 9.5% (0.64 – 18.4) 
6 30 (14.5%) 6 20% (5.69 – 34.31) 
7 30 (14.5%) 9 30% (13.6 – 46.4) 
Total 206 (100%) 19 (100%) 9.2% (5.27 – 13.17) 
 
 
 
 
 
 
 
TABLE - 25 
ABCD2 
Score Patients 
Stroke in 30 
days 
% Risk (95% CI) 
<1 2 (1%) 0 0 
2 28 (13.5%) 0 0 
3 32 (15.5%) 0 0 
4 42 (20.5%) 1 2.4% (0 -6.99) 
5 42 (20.5%) 4 9.5% (0.64 – 18.4) 
6 30 (14.5%) 6 20% (5.69 – 34.31) 
7 30 (14.5%) 9 30% (13.6 – 46.4) 
Total 206 (100%) 19 (100%) 9.2% (5.27 – 13.17) 
 
TABLE - 26 
ABCD2 
Score Patients 
Stroke in 90 
days 
% Risk (95% CI) 
<1 2 (1%) 0 0 
2 28 (13.5%) 0 0 
3 32 (15.5%) 0 0 
4 42 (20.5%) 1 2.4% (0 -6.99) 
5 42 (20.5%) 6 14.2% (3.71 – 24.87) 
6 30 (14.5%) 6 20% (5.69 – 34.31) 
7 30 (14.5%) 11 36.6% (19.43 – 53.91) 
Total 206 (100%) 24 (100%) 11.6% (7.27 – 16.03) 
 
A total of 24 patients developed stoke within 3 months. The 90 day risk of developing 
stroke was 11.6%. 11 of these occurred in first 2 days. The risk was highest in patients 
with score of 7. The risk being 13%, 30% and 36.6% at 2, 30 and 90 days respectively. 
There was no difference between the 7th day and 30th day risk. Patients with score 
between 0 and 3 did not develop stoke within 90 days. There was no mortality within 90 
days. 
 TREATMENT OUTCOME AFTER 7 DAYS: TABLE - 27 
Out of 38 patients who received heparin, 5 (13.2%) developed stroke within 7 days while 
14 patients (8.3%) in non heparin group developed stroke. Although the proportion of 
patients in heparin group was higher, it was not statistically significant 
 
 Total Stroke  No Stroke p value 
 Heparin 
 group 
38 5 (13.2%) 33 (86.8%)  0.527 
 
Non Heparin  
 group 
168 14 (8.3%) 154 (91.7%) 
Total 206 19 (9.2) 186 (90.8)  
 
 
 
 
 
DISCUSSION 
AGE: The maximum number of patients were in the age group between 50 and 59 years 
followed by the age group between 40 and 49, 60 and 69 years. The mean age of studied 
population was 54.4 ± 10.1 years. 
    K. E. Murros et al in 1989 reported the mean age in his study population as 67.4 
years[67]. Christian W et al., in 2002 reported the mean age of TIA in German population 
as 66.4 years [68]. 
Kimura et al in his study reported the mean age of 65.7±10.3 years from Osaka, 
Japan[69] While Takeshi I et al in his 2004 study of 1084 patients gives the mean age as 
70.8 years[70]. The maximum patients were in age group of 65 to 74 years and 75 to 84 
years. 34.5% were in 65 to 74 years group while 24.3% were in the 65 to 74 year group. 
Nearly 10% were above 85 years. 
The mean age in our study was one decade earlier compared to the above studies. This 
could be due to the fact that Indian population develop stroke one to two decades earlier 
than that of the Western population, because of early atherosclerosis and increasing 
number of young hypertension and diabetes patients. This may also be a reflection of the 
demographic profile of the population being studied. 
SEX: There were 116 males (56.3%) and 90 females (43.7%) among the 206 patients in 
this study showing a general male preponderance. This is in keeping with what has been 
reported earlier.[19-21] 
 
 AGE DISTRIBUTION BASED ON SEX:  
Age distribution based on the sex in our study showed that among the males, 70.7% of 
cases were in the age group between 40 and 59 years. But 61.1% females were in the age 
group between 50 and 69 years. The mean age in our study was 52.4 + 10.2 for men, 56.6 
+ 10.6 for women. More number of females developed TIA at a later age compared to 
males.  
HYPERTENSION: 
Arterial hypertension is defined as systolic BP greater than 140 mm. Hg. or diastolic BP 
greater than 90 mm Hg. It is one of the most important and effective modifiable risk 
factors. But unfortunately it remains untreated or under treated (Hajjar and Kotchen, 
2003) [71]. It predisposes to ischemic stroke by aggravating atherosclerosis and increases 
the relative risk for stroke three to four fold. Blood pressure treatment, resulting in 
modest reduction in SBP of 10 to 12 mm Hg. and 5 to 6 mm Hg. Diastolic BP is 
associated with a 38% reduction in stroke incidence. (MacMohan and Rodgers, 1996) 
[72]. 
In our study, hypertension was present in 62.6% of patients and around 33.3% of these 
patients had hypertension of more than five years duration. 
According to Lausanne stroke registry, hypertension was seen in 45.5% of patients [73]. 
Takeshi Inoue et al in 2004 reported that nearly 53% of patients with TIA had 
hypertension. Ricci S et al from the SEPIVAC study reported a prevalence of 43.6% [74]. 
The increased incidence of hypertension in our study could be due to general increase in 
HT population in Southeast Asia. 
According to Trivandrum Stroke Registry, hypertension was seen in 80% of stroke 
patients, which was slightly higher than our study [75] 
From German Stroke Data Bank, Christian Weimar et al in 2002 reported a prevalence of 
62.9% in TIA patients [68]. This is similar to what was seen in our study.  
DIABETES MELLITUS: 
DM is associated with stoke, independently of the various cardiovascular risk factors 
which usually accompany this disease. Indeed, the relative risk of stroke of all ages was 
1.8 for diabetic men and 3.0 for diabetic women (Shinton and Beever, 1989, Burchfield et 
al 1994) [76,77]. 
In our study, diabetes mellitus was found in 44.6% of patients. 43% of these patients had 
diabetes of more than five years duration. 10% of these patients were diagnosed to have 
DM during this present admission, after having ruled out the possibility of stress induced 
hyperglycemia with the help of HbA1C and follow up blood glucose testing after one 
week to ten days. 
Barcelona stroke registry documented 21% of patients with diabetes among the ischemic 
strokes. [78] 
Kazumi Kumra et al reported 24% of diabetes among TIA patient. While Takeshi I et al 
reported a low of 16%. Christian Weimar et al reported that 21.6% had diabetes [68]. 
14.9% had diabetes in SEPIVAC study from Italy [74]. 
The increase in diabetic population in our study reflected the general increase in the 
incidence of diabetes in the Southeast Asia. 
SMOKING: 
It raises the blood fibrinogen, enhances platelet aggregation and increases the hematocrit 
level and blood viscosity. Smoking cessation substantially decreases the risk for 
subsequent stroke. The incidence of stroke is 50% higher in smokers. 
Our study showed that 93 patients out of total 206 patients (45.1%) were found to be 
smokers currently. 76% of these patients were smokers of more than 10 years duration. 
Among these 93 patients, 91 were males and 2 were females. 
Kazumi Kumra et al reported that nearly 50% of TIA patient had a history of smoking 
[69]. While 18.5% were smokers in Takeshi I et al report [70]. 24.1% of TIA patients 
were smokers in German Stroke Data Bank (Christian Weimar et al) [68] and 28.7% 
were smokers in Ricci S et al study [74]. So the prevalence varies widely among the 
various population studied. 
ALCOHOLISM: 
Chronic heavy alcohol consumption and binge drinking may exert their harmful effects 
through changes in Blood Pressure, platelet aggregability, blood coagulation and the level 
of triglycerides. 
In this study, 73 patients were alcoholic (35.4%) among the total 206 patients. Of these 
73 patients, 67 were males and 6 were females. Around 70% of these patients were 
alcoholic for more than 10 years duration. 
DYSLIPEDEMIA: 
84 patients out of 206 in our study had hypercholesterolemia (40.7%). And nearly 85% 
had serum triglyceride levels > 150 mg/dL. While Takeshi Inoue et al reported a 
prevalence of 18% [70]. Data from German Stroke Data Bank give a figure of 40.1% 
[68]. This is in keeping with what is seen in our report. Dyslipidemia esp 
hypertriglyceridemia seems to be more prevalent in Indian population compared to the 
western population. This could be because of the genetic makeup as well as the higher 
prevalence of diabetes among Indian population. 
PRIOR TIA: 
History of prior TIA was seen in 67 patients (28%). This is same as what has been 
reported by Christian Weimar et al from German Stroke Data Bank analysis [68]. While 
Kimura et al in his study reported a much lower proportion of 18% [69].  
PRIOR STROKE: 
43 out of 206 patients (20.8%) had a history of stroke in the past in our study. This is 
almost similar to the report from Germany by Christian Weimar et al of 21.2% [68]. and 
from Japan by Kimura et al who reported 23% [69]. 
ATRIAL FIBRILLATION: Atrial Fibrillation was seen in 24 patients out of 206 
(11.7%). This is almost similar to what was reported by Weimar C, Kraywinkel K, Rodl 
J, et al; German Stroke Data Bank Collaborators (11%) [68]. Johnston SC et al reported 
that 9% of 1707 TIA patients (mean age, 72 years) in 16 hospitals in northern California 
had AF [58]. Ricci S et al study in 1991 reported 9.6% of TIA patients had AF [74]. 
While higher values of 15% and 18% were reported by Kimura et al and Takeshi I et al in 
their studies respectively [69,70]. Japanese are reported to be at lower risk for 
atherosclerosis of the extracranial carotid artery than Caucasians.16 Therefore, the 
proportion of TIA patients with AF may be relatively higher in Japanese than in 
Caucasians and South Asians. 
CLINICAL FEATURES 
WEAKNESS 
Motor weakness was the commonest clinical presentation and was seen in 65.53% in this 
study. Among the 135 patients, Right side weakness was found in 53 patients (25.72%) 
and Left side weakness was seen in 82 patients (39.81%). 
SPEECH DISTURBANCE 
Speech disturbance was the next common symptom seen in 40.77% (aphasia constituted 
16.2% and dysarthria 24.57%). Aphasia was seen in 33 patients among the 206 patients 
(16.2%). Of these 33 patients, 21 patients (66.6%) had right side weakness and 3 patients 
(9.1%) had left side weakness. Aphasia as the only clinical manifestation was seen in 4 
patients while 5 patients had other symptoms in addition to aphasia 
SENSORY DISTURBANCE 
It was seen in 30 patients out of the 206 patients (14.56%). Sensory disturbance as the 
only symptom occurred in 2 patients. 
OTHER SYMPTOMS 
Gait disturbance, loss of consciousness, dizziness/vertigo, nausea/vomiting, visual 
disturbance were other commonly reported symptoms. Headache during presentation was 
seen in only 6 patients. Other rare symptom like limb shaking TIA was seen in 1. 
TERRITORIAL DISTRIBUTION 
115 out of 206 (55.82%) patient has symptoms related to carotid territory while 63 
(30.58%) had symptoms of vertebrobasilar territory. 8 patients (3.38%) had mixed 
symptoms while in 20 patients it was uncertain. This is similar to what has been reported 
in Rochester [79], and Tartu studies [80] and by C Fieschi, F Mariani et al from Italian 
multicenter study of reversible cerebral ischemic attacks in 1983 [81]. Fratiglioni and 
Arfaioli et al in 1989 reported more of vertebrobasilar TIAs (VB 48.8% and CA 23.3%) 
[82]. 
DURATION OF SYMPTOM: 
There was no significant difference between the proportion of patients with short duration 
(< 60 min, 102 patients) and long duration (> 60 min, 104 patients) TIAs in our study. 
Although epidemiological studies to date have not investigated the duration of symptoms 
in TIAs, other hospital-based studies have reported a mean duration of 207 minutes and 
symptoms lasting more than 30 minutes in 50% of all patients with TIAs. 
An analysis from the German Stroke Data Bank by Christian Weimar et al has shown a 
high prevalence of long-duration TIAs (70%) [68]. 
CLINICAL CHARECTERISTICS IN TIA PATIENTS WITH ATRIAL 
FIBRILLATION 
Our study showed an association between AF and 5 clinical features: (1) age ≥ 60 years, 
(2) disturbance of consciousness, (3) nausea and vomiting, (4) dizziness/vertigo and (5) 
gait disturbance during TIA.  
      Consciousness disturbance was more frequent in AF group than in non-AF group. 
This finding is similar to what has been reported by Takeshi Inoue and Kazumi Kimura 
in their study [69,70]. They hypothesized that Emboli originating from the left atrium 
may be larger than those originating from ulcerated arterial atheroma. Transient embolic 
occlusion of a larger artery may have occurred in TIA patients with AF and not in those 
without AF. Conversely, microemboli from carotid disease can travel easily through the 
large cerebral arteries and lodge in the small artery, resulting in mild neurologic deficits.      
      Takeshi Inoue and Kazumi Kimura et al also noted in their study that AF patients had 
more speech disturbance compared to non-AF group [69,70]. This was not seen in our 
study. Nausea/vomiting and dizziness/vertigo were more frequent in the non-AF group 
than in the AF group while gait disturbance was more common in AF group. 
  
TRANSIENT SYMPTOMS WITH INFARCTION 
       The awareness that a classically defined TIA (<24 hours in duration) can be 
associated with irreversible ischemic brain injury led to a proposal to label these events as 
"transient symptoms associated with infarction" (TSI) or "cerebral infarction with 
transient signs (CITS)" and to distinguish them from transient symptoms without 
infarction by Ay H; Koroshetz WJ et al in 2005 [4]. 
       While TSI in general has smaller infarct volumes than classically defined ischemic 
stroke (where neurologic deficits persist for ≥ 24 hours), there is no unique size that 
differentiates TSI from ischemic stroke [4] . 
      Patients with TSI have a higher short-term risk of recurrent ischemic stroke than 
patients who have transient symptoms without infarction. This conclusion is supported by 
a number of head CT and DWI studies [4-8] 
        The reported prevalence of cerebral infarction in TIA patients has varied 
considerably. In 1976, Kinkel and Jacobs [83] re-ported no CT abnormalities in 32 
patients. However, most subsequent studies have reported frequencies ranging from 20% 
to 40% [84-86]. The 22.2% prevalence in our sample is in confirmation with this view.  
RELATIONSHIP OF SYMPTOM DURATION AND INFARCTION:  
Bogousslavsky and Regli in 1985 [84] found that the mean duration of the TIAs without 
infarct was significantly shorter (21min) than that of the TSI (358 min). But Calandre et 
al. in their 1984 report [85] did not show any relationship between the duration of 
symptom and the frequency of abnormal CT scans. 
    Recently some reports using DWI suggest that increased duration of classically defined 
TIA (<24 hours in duration) is associated with a higher probability of infarction, but the 
association is not absolute [4, 9-12]. A systematic analysis of patients with classically 
defined TIA found that symptom duration was not a reliable predictor for the presence of 
infarction, even though the mean duration tended to be significantly longer in patients 
with infarction than in those without infarction.  
     In our study there was no significant difference in duration of TIA between the two 
groups.  
      Analysis of associations among risk factors and CT infarcts shows that Carotid 
stenosis greater than 50%, hypertension and older age each significantly increased the 
incidence of cerebral infarctions in our study. This is similar to what has been shown by 
K. E. Murros and G.W. Evans in 1989 [67].  
      Awad et al. [87] reported a slightly higher incidence of cerebral infarction in 
vertebrobasilar patients than in carotid patients, while Berguer et al. [88] reported a 
significantly greater incidence of infarction in patients with carotid TIAs. In our scans, 
infarction prevalence was slightly higher in carotid than vertebrobasilar patients (23.3% 
and 21.5%) but it was not statistically significant. 
  Although we did not look at the interval between the date of TIA and the appearance of 
CT finding, previous reports have failed to see any significant association between the 
two.  
ABCD2 SCORE AND THE RISK OF DEVELOPING STROKE AT 2, 7, 30 AND 90 
DAYS 
          The California score and the ABCD score both reliably predicted short-term risk of 
stroke after presentation with TIA. Johnston et al in 2007 and others subsequently have 
validated that the unified scoring system of ABCD2 has better predictive value compared 
to the either scoring system alone [58,60]. This score predicts the 2 day risk better than 
the other scores. They also stratified patients in to three groups according to the score: (1) 
Score 6 to 7: High two-day stroke risk (8.1 percent), (2) Score 4 to 5: Moderate two-day 
stroke risk (4.1 percent), (3) Score 0 to 3: Low two-day stroke risk (1.0 percent). In our 
study 62 (30.1%) patients were in low risk group, 84 (40.8%) in moderate risk, while 60 
(29.1%) were in high risk group. While the overall risk stratification was similar to the 
study from Johnston et al, there were higher number of patients with a score of 7 (14.5%) 
in our study compared to the study from Johnston et al (4.2%) [58]. This may be because 
of larger proportion of patients with diabetes and hypertension in our study population. 
          A total of 24 patients developed stoke within 3 months in our study. The 90 day 
risk of developing stroke was 11.6%. Almost half of them (11 strokes) occurred in first 2 
days. This is similar to what has been previously reported by Johnston et al (50%) [58]. 
The risk was highest in patients with score of 7. The risk being 13%, 30% and 36.6% at 
2, 7 and 90 days respectively.  
The overall risk of developing stroke at 2nd, 30th and 90th day were 5.3%, 9.2% and 11.6% 
respectively in our study. This is similar to a meta-analysis of 11 observational studies 
published through December 2006 were the risk of stroke at 2 days, 30 days, and 90 days 
after TIA was 3.5, 8.0, and 9.2 percent, respectively [45] . In the three studies that used 
active ascertainment of stroke outcome (ie, face-to-face evaluation by a practitioner at 
three months rather than use of administrative data), the 2, 30, and 90 day risk of stroke 
after TIA was even higher (9.9, 13.4, and 17.3 percent, respectively). Similar findings 
were reported in a meta-analysis of 18 cohorts published through June 2007 [48] 
            Patients with score between 0 and 3 did not develop stoke within 90 days. There 
was no mortality within 90 days in our study while other studies have shown differently. 
A large hospital-based study in San Francisco, Calif, reported a mortality rate of 2.6% 
within the first 90 days, of which 44% of deaths were due to a new stroke. German 
Stroke Data Bank analysis study reported a lower percentage of 1.7% [68]. This 
discrepancy may be because of the smaller number of patients analyzed in our study. 
 
TREATMENT OUTCOME AFTER 7 DAYS 
Since the maximum stroke risk is within 7 days, it is important that these patients are 
quickly evaluated and appropriately treated at the earliest. Appropriate treatment depends 
upon the pathophysiological mechanism behind the ischemic event. Although all stoke 
patients in our study received aspirin (150mg/d) and statin (atorvastatin 20mg/d) we 
hypothesized that patients falling under high risk could benefit from treatment with 
subcutaneous heparin. There were no big studies analyzing the use of heparin in high risk 
TIAs. In one small trial involving 449 patients, a low-molecular-weight heparin did not 
reduce the risk of recurrent stroke during the first 14 days after a stroke that was 
attributed to atrial fibrillation [89]. However, in a large subgroup (3169 patients) of 
similar patients in a trial of subcutaneous unfractionated heparin, heparin reduced the 14-
day risk of ischemic stroke by more than 50 percent, but an increase in brain hemorrhage 
eliminated this benefit [90]. Given the lower risk of hemorrhage with smaller infarcts 
[91], the risk of brain hemorrhage is probably greater after a stroke than after a transient 
ischemic attack, so the net benefit of such therapy after a transient ischemic attack may 
be greater.  
            Out of 38 patients who received heparin, 5 (13.2%) developed stroke within 7 
days while 14 patients (8.3%) in non heparin group developed stroke. None of the strokes 
in heparin group were hemorrhagic. Although the proportion of stoke patients in heparin 
group was higher, it was not statistically significant.  
CONCLUSION 
• The maximum number of patients were in the age group between 50 and 59 years. 
(35.92%). Compared to western population, TIA in our study population occurred 
a decade earlier. 
• TIAs occurred more frequently in males (56.3%) than in females (43.7%) showing 
a general male preponderance of the disease. Males predominated in the age group 
between 40 and 59 years (70.7%), while females predominated in the age group 
between 50 and 69 years (61.1%) indicating that females developed TIA at a later 
age compared to males. 
• Common risk factors were hypertension (62.6%), hyperlipidemia (40.7%), 
diabetes mellitus (44.6%), smoking (45.1%) and alcoholism (35.4%). 
Modification of lifestyle and proper management of these modifiable risk factors 
might play a major role in the primary and secondary prevention of ischemic 
stroke. 
• Motor weakness was the commonest clinical presentation and was seen in 65.53% 
in this study. Speech disturbance was the next common symptom seen in 40.77% 
(aphasia constituted 16.2% and dysarthria 24.57%). 
• There was no significant difference between the proportion of patients with short 
duration (< 60 min, 102 patients) and long duration (> 60 min, 104 patients) TIAs 
in our study. 
• Our study showed an association between AF and 5 clinical features: (1) age ≥ 60 
years, (2) consciousness disturbance, (3) nausea and vomiting, (4) 
dizziness/vertigo and (5) gait disturbance during TIA. Consciousness disturbance 
and gait disturbance were more frequent in AF group than in non-AF group. 
• 22.2% of patients without prior history of stroke had positive CT imaging after 
TIA. 
• There was no significant difference in duration of TIA between the CT positive 
and CT negative group. 
• There was a significant association between older age, hypertension and Carotid 
stenosis (>50%) and presence of infarct in CT. 
• Infarction prevalence was slightly higher in carotid than vertebrobasilar patients 
(23.3% and 21.5%) but it was not statistically significant. 
• According to ABCD2 score 62 (30.1%) patients were in low risk group, 84 
(40.8%) in moderate risk, while 60 (29.1%) were in high risk group in our study. 
• The proportion of patients with a score of 7 (14.5%) was higher in our study. 
• The overall risk of developing stroke at 2 days, 7 days and 90 days were 5.3%, 
9.2% and 11.6% respectively in our study. The risk at the end of 30 days was same 
as 7 day risk. 
• Patients with score between 0 and 3 did not develop stoke within 90 days. And 
there was no mortality within 90 days in our study. 
• Administration of heparin did not significantly alter the development of stroke at 7 
days in high risk group. 
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Clinical and Imaging Features of Transient Ischaemic 
Attack and the Utility of ABCD2 Score 
PROFORMA 
Name:    Age/Sex:      IP No: 
Address:        Phone No: 
Presenting symptoms: 
• Consciousness disturbance      Ye s  No 
• Speech   confused or word-finding difficulty 
 hoarse 
• Visual  could not see from one eye when good eye covered 
 could not see half of objects with one eye or both eyes open 
 diplopia/double vision 
 completely blind 
• Dizziness/vertigo        Ye s  No 
• Imbalance        Ye s  No 
• Numbness                                         Ye s  No 
• Limb weakness and/or numbness    
• Facial droop or numbness    
• Gait disturbance       Ye s  No 
• LOC         Ye s  No 
Other symptoms  : 
Duration of symptoms: 
No.  
  
Past and Personal History: 
History of stroke :    Ye s  No 
Hypertension :    Ye s  No 
Diabetes mellitus :    Ye s  No 
Hyperlipidemia :    Ye s  No 
Smoking:     Ye s  No 
Drugs/Medications:    Ye s  No 
Ischemic Heart Disease                    Ye s  No 
Neurological Examination : 
Cardiovascular Examination:  B.P: 
     Pulse: 
     Carotids: 
     Peripheral Vessels: 
     Heart sounds : 
    
Other System Examination:  
ABCD2 Score:  
 
 
Investigations: 
 • Hb:   TC:    DC: P      L     E 
• ESR 
• Fasting blood glucose 
• Blood urea:   mg/dl   Serum creatinine:  mg/dl 
• Electrolytes:  
• Fasting lipid profile: Total Cholesterol: 
                                   Total: 
                                   HDL: 
               Triglycerides: 
Imaging:  
CT Brain: 
MRI Brain: 
 
Transcranial Doppler:  
 
Carotid and Vertebral Doppler: 
Intimal-medial thickness (IMT) 
TREATMENT: 
 
      Heparin:  
 
       LMWH / Unfractionated, Duration of treatment: 
 
Antiplatelets                     Statin 
 
OUTCOME : 
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